These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 5818088

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M, Chandramouli N, Martinez J, Walter R.
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S, Schwartz IL, Walter R.
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract] [Full Text] [Related]

  • 25. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R, Smith CW, Roy J, Formento A.
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF, Nestor JJ, Ferger MF, Du Vigneaud V, Chan WY.
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis and some pharmacological properties of (2-tryptophan)-oxytocin.
    Ferrier BM, Branda LA.
    Can J Biochem; 1976 May; 54(5):512-6. PubMed ID: 1276976
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z, Lammek B, Gazis D, Schwartz IL.
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [Abstract] [Full Text] [Related]

  • 33. Some pharmacological properties of (4-leucine)-arginine-vasotocin.
    Pliska V, Vasák J, Rufer M, Rudinger J.
    Experientia; 1973 Feb 15; 29(2):171-3. PubMed ID: 4692755
    [No Abstract] [Full Text] [Related]

  • 34. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW, Chowdrey HS, Hope DB, Nilwises N, Wälti M.
    Br J Pharmacol; 1979 Dec 15; 67(4):575-85. PubMed ID: 519108
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis and pharmacological properties of deaminotocinamide and a new synthesis of tocinamide.
    Hruby VJ, Ferger MF, Du Vigneaud V.
    J Am Chem Soc; 1971 Oct 20; 93(12):5539-42. PubMed ID: 5165679
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S, Felix AM, Meienhofer J, Smith CW, Walter R.
    J Med Chem; 1977 Apr 20; 20(4):495-500. PubMed ID: 850234
    [Abstract] [Full Text] [Related]

  • 39. [Vasopressin and Oxytocin. Physiological and pharmacological basis for the clinical use of the posterior pituitary gland hormones].
    Rauch R.
    Dtsch Med Wochenschr; 1969 Dec 12; 94(50):2611-4. PubMed ID: 4901915
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.